jy7d9sh | Knowledge4COVID-19

Property	Value
?:abstract	Remdesivir (Veklury) is the first antiviral drug approved to treat patients ages 12 and older who are hospitalized with COVID-19.The drug is administered via slow IV infusion.Elevated liver enzymes are common with treatment. Hypersensitivity reactions, including anaphylaxis, are possible.
is ?:annotates of	<https://research.tib.eu/covid-19/entity/8jy7d9sh_hasAnnotation_C0003451> <https://research.tib.eu/covid-19/entity/8jy7d9sh_hasAnnotation_C0013227> <https://research.tib.eu/covid-19/entity/8jy7d9sh_hasAnnotation_C0020517>
?:creator	<https://research.tib.eu/covid-19/entity/Aschenbrenner%2C_Diane_S>
?:doi	<https://research.tib.eu/covid-19/entity/10.1097/01.naj.0000731640.35662.2c>
?:doi	10.1097/01.naj.0000731640.35662.2c
?:journal	The_American_journal_of_nursing
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33350691>
?:pmid	33350691
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/8jy7d9sh_HAS_C4726677_TREATS_C5203670>
?:source	Medline
?:title	Remdesivir Approved to Treat COVID-19 Amid Controversy.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2021-01-01

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/8jy7d9sh>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/8jy7d9sh>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all